Michael Barbella, Managing Editor02.17.23
Endoluxe has entered into a know-how agreement with Mayo Clinic to research the use of artificial intelligence (AI) and machine learning in improving bladder canceroutcomes.
Mayo Clinic will utilize the Endoluxe Visualization System, a wireless endoscopic “smart” camera platform, and its edge computing attributes, which provide AI-powered clinical insights to clinicians and can lead to better patient outcomes. Endoluxe's technology platform provides clinicians real-time data and clinical insights onscreen during a surgical procedure–an important tool that no other endoscopic platform currently offers, the company claims.
“Working with Mayo Clinic clinicians will further advance Endoluxe’s surgical insights capabilities. We are excited to accelerate our cutting-edge technology platform for the benefit of patients,” Endoluxe Chief Medical Officer Dr. Phil Zhao said.
Endoluxe is an endoscopic video imaging organization based in the United States, with worldwide distribution of its medical industry design award-winning Endoluxe Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption, and improving patient outcomes through better therapy application. Endoluxe is committed to being a vendor-agnostic platform that allows customers to utilize their existing investment in traditional scopes and supporting devices—while taking advantage of future technological advancements using our portable, integrated and feature-laden platform at one-quarter the cost of legacy products.
Mayo Clinic will utilize the Endoluxe Visualization System, a wireless endoscopic “smart” camera platform, and its edge computing attributes, which provide AI-powered clinical insights to clinicians and can lead to better patient outcomes. Endoluxe's technology platform provides clinicians real-time data and clinical insights onscreen during a surgical procedure–an important tool that no other endoscopic platform currently offers, the company claims.
“Working with Mayo Clinic clinicians will further advance Endoluxe’s surgical insights capabilities. We are excited to accelerate our cutting-edge technology platform for the benefit of patients,” Endoluxe Chief Medical Officer Dr. Phil Zhao said.
Endoluxe is an endoscopic video imaging organization based in the United States, with worldwide distribution of its medical industry design award-winning Endoluxe Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption, and improving patient outcomes through better therapy application. Endoluxe is committed to being a vendor-agnostic platform that allows customers to utilize their existing investment in traditional scopes and supporting devices—while taking advantage of future technological advancements using our portable, integrated and feature-laden platform at one-quarter the cost of legacy products.